scholarly journals Effect of Glycemic Treatment and Microvascular Complications on Menopause in Women With Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort

Diabetes Care ◽  
2013 ◽  
Vol 37 (3) ◽  
pp. 701-708 ◽  
Author(s):  
Catherine Kim ◽  
Patricia A. Cleary ◽  
Catherine C. Cowie ◽  
Barbara H. Braffett ◽  
Rodney L. Dunn ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Microvascular Complications ◽  
Diabetes Control ◽  
Diabetes Interventions

scholarly journals Hearing Impairment and Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort

Diabetes Care ◽  
2018 ◽  
Vol 41 (12) ◽  
pp. 2495-2501 ◽  
Author(s):  
David S. Schade ◽  
Gayle M. Lorenzi ◽  
Barbara H. Braffett ◽  
Xiaoyu Gao ◽  
Kathleen E. Bainbridge ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Hearing Impairment ◽  
Diabetes Control ◽  
Diabetes Interventions

Beyond the Diabetes Control and Complications Trial—Addressing Weight Gain in Type 1 Diabetes

2008 ◽  
Vol 04 (01) ◽  
pp. 62 ◽  
Author(s):  
Jonathan Purnell
Keyword(s):  
Type 1 Diabetes ◽  
Weight Gain ◽  
Microvascular Complications ◽  
Intensive Therapy ◽  
Diabetes Control ◽  
Controlled Clinical Trial ◽  
Normal Range ◽  
Randomised Controlled ◽  
Blood Glucose Concentrations

The Diabetes Control and Complications Trial (DCCT) was a prospective, randomised, controlled clinical trial that began in the 1980s and was carried out over a decade to determine whether intensive treatment aimed at maintaining blood glucose concentrations close to the normal range could decrease the frequency and severity of microvascular complications in patients with type 1 diabetes. The results showed that intensive therapy effectively delays the onset and progression of diabetic retinopathy, nephropathy, and neuropathy in patients with type 1 diabetes.1The side effects associated with intensive therapy were a nearly three-fold increased frequency of severe hypoglycaemia and greater weight gain. For the majority of patients with type 1 diabetes, the benefits of intensive therapy were considered to vastly outweigh these risks. However, the potential detrimental effects of weight gain, especially on macrovascular risks, are being revisited.

Sign in / Sign up

Export Citation Format

Share Document